These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10912165)

  • 21. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 22. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guideline for treatment respiratory infections].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2009 Dec; 32(12):437. PubMed ID: 20088344
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-infective therapy of upper respiratory tract infections].
    Gnehm HE
    Ther Umsch; 1984 May; 41(5):318-23. PubMed ID: 6740524
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibiotic resistance in respiratory tract infections: what can we do?].
    Flückiger U
    Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new generation of fluoroquinolones--new possibilities for the treatment of respiratory community-acquired infections].
    Iakovlev SV
    Antibiot Khimioter; 2001; 46(6):38-42. PubMed ID: 11573324
    [No Abstract]   [Full Text] [Related]  

  • 27. Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
    Niki Y; Tamada S; Nakabayashi M; Soejima R
    Drugs; 1995; 49 Suppl 2():420-2. PubMed ID: 8549385
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute seasonal respiratory tract infections. Even legionellas participate significantly].
    MMW Fortschr Med; 2000 Nov; 142(44):52. PubMed ID: 11107810
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fluoroquinolones in the treatment of respiratory infections].
    Stahlmann R
    Pneumologie; 1999 Nov; 53(11):521-9. PubMed ID: 10613068
    [No Abstract]   [Full Text] [Related]  

  • 30. Community-acquired bacterial respiratory tract infections.
    Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
    J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?].
    Garau J
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():43-6; discussion 47-52. PubMed ID: 10344098
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibacterial chemotherapy of bronchopulmonary infections].
    Trendelenburg F
    Dtsch Med J; 1972; 23(7):469-72. PubMed ID: 5078544
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antimicrobial drugs for adults in outpatient clinics].
    Valtonen M
    Duodecim; 1991; 107(10):843-9. PubMed ID: 1364727
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacteriology in community-acquired respiratory pathology].
    Weber P
    Presse Med; 1998 Mar; 27(11):546-8. PubMed ID: 9767971
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibiotics in primary care: focus on fluoroquinolones and other new and investigational antimicrobial agents.
    Pau AK; Slone RB
    Lippincotts Prim Care Pract; 1999; 3(1):39-54. PubMed ID: 10214201
    [No Abstract]   [Full Text] [Related]  

  • 37. [Suggestions for the common cold season. Managing cough, rhinitis and earaches].
    Adam D
    MMW Fortschr Med; 2002 Jan; 144(1-2):46-9. PubMed ID: 11847883
    [No Abstract]   [Full Text] [Related]  

  • 38. Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
    Norrby SR
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():99-101. PubMed ID: 9484879
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibacterial and immunomodulating therapy of respiratory tract diseases].
    Sil'vestrov VP; Karaulov AV
    Ter Arkh; 1983; 55(3):3-9. PubMed ID: 6344301
    [No Abstract]   [Full Text] [Related]  

  • 40. [Levofloxacin for prevalent infections in primary care medicine].
    Redondo Sánchez J
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():29-33. PubMed ID: 10563108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.